What's in a Number?
Deborah A. Boyle, RN, MSN, AOCNS®, FAAN, August 27, 2012
Cancer statistics do not overwhelm me as much as other calculations do. I think this is because I can imagine a human being connected to the rising incidences and changing trends within my chosen specialty.
Current Treatment Options for Non–Small-Cell Lung Cancer
Elizabeth S. Waxman, RN, MSN, NP-C1 , August 27, 2012
Chemotherapy is now employed in earlier-stage disease in neoadjuvant, adjuvant, and combined-modality treatments. The aim of this article is to review the current systemic treatments for NSCLC.
Falls in Older Adults With Cancer: A Call to Action
Deborah A. Boyle, RN, MSN, AOCNS®, FAAN , August 27, 2012
The prevention of patient falls is a major healthcare imperative. Falls are associated with avoidable morbidity and mortality, compromised quality of life, and considerable economic burden.
A Patient With Tumor Lysis Syndrome
Jeanne Held-Warmkessel, MSN, RN, AOCN®, ACNS-BC1 , August 27, 2012
Tumor lysis syndrome (TLS) is a potentially life-threatening metabolic disorder characterized by an elevated uric acid level, elevated serum potassium and phosphorus levels, and a decreased calcium level.
Clinical Hypnosis for the Palliative Care of Cancer Patients
Gary Elkins, PhD,1 William Fisher, MA,1 Aimee Johnson, BA,1 Jim Sliwinski, MA1, Guest Editor, Georgia M. Decker, ANP-BC, AOCN® , August 27, 2012
Clinical hypnosis has been defined as a mind-body therapy that involves a deeply relaxed state, individualized mental imagery, and therapeutic suggestion.
Vismodegib, a Hedgehog Pathway Inhibitor for Adults With Locally Advanced or Metastatic Basal Cell Carcinoma
Gail M. Wilkes, MS, APRN-BC, AOCN1 , August 27, 2012
Vismodegib is for the treatment of adults with metastatic basal cell carcinoma, or locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery, and who are not candidates for radiation.